MedPath
FDA Approval

Lorbrena

U.S. Pharmaceuticals (DUNS: 829076905)

March 22, 2023

HUMAN PRESCRIPTION DRUG LABEL

lorlatinib(25 mg in 1 1)

Manufacturing Establishments (4)

Pfizer Pharmaceuticals LLC

U.S. Pharmaceuticals

829084552

Pfizer Ireland Pharmaceuticals

U.S. Pharmaceuticals

985052076

Pharmacia & Upjohn Company LLC

U.S. Pharmaceuticals

618054084

Pfizer Manufacturing Deutschland GmbH

U.S. Pharmaceuticals

341970073

Products (1)

Lorbrena

63539-927

NDA210868

NDA (C73594)

ORAL

March 22, 2023

Code: OSP71S83EUClass: ACTIBQuantity: 25 mg in 1 1
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
© Copyright 2025. All Rights Reserved by MedPath